Cuts to Medicare reimbursement could prevent cancer patients from accessing care and force practices to downsize or close, radiation oncologists say.

The fact that this study showed a significant difference in its primary end point and the objective response rate suggests that FOLFIRINOX should be considered as a standard of care,” researchers ...

President Donald Trump's claim that prescription drug prices will be reduced “almost immediately" under a new executive order is misleading.

Most-favored-nation pricing is “founded on incorrect assumptions about where high out-of-pocket costs really come from and what it would mean for the US to adopt cost-effectiveness standards used by ...

In the APOLLO trial, first-line treatment with anlotinib plus penpulimab improved progression-free survival and overall survival when compared to sorafenib.

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years of age and older and high-risk individuals aged 12-64 years.

The FDA has approved Zynyz (retifanlimab-dlwr) to treat patients with squamous cell carcinoma of the anal canal.

The FDA has approved Emrelis to treat adults with locally advanced or metastatic NSCLC with high c-Met protein overexpression.

Working with an incompletely staffed team more than 25% of the time is associated with greater odds of burnout for physicians, data suggest.

Patients with prostate cancer may have a lower risk of recurrence if they take multivitamin supplements after diagnosis, new data suggest.

Rhenium-SCT is an epidermal radionuclide therapy that utilizes a radioisotope-based resin to treat shallow non-melanoma skin ...

One thing that hasn’t changed since 2017 is the strong defense of Medicaid from Democrats, hospital executives, and consumer ...